ArticleAsian Pacific journal of cancer prevention : APJCP2025
Interleukin-13 (rs20541 A/G) Gene Polymorphism and Chance of Acquiring Hepatitis B in the Egyptian Population.
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
CONTEXT AND
objectiveAn important worldwide health concern is infection with the hepatitis B virus (HBV), especially in underdeveloped nations. Gene polymorphisms encoding pro- and anti-inflammatory cytokines can influence how an HBV infection presents clinically. As mediators, cytokines play important functions in the immunological and inflammatory systems. A strong pleiotropic cytokine is interleukin-13 (IL-13). The research attempts to look into the relationship between HBV infection in Egyptians and variations in a single nucleotide in the IL-13 (rs20541 A/G) gene. MATERIALS AND
methodsOne hundred and twelve hepatitis B cases and fifty control subjects were involved in the investigation. Utilizing an allelic discrimination test pre-validated TaqMan™ MGB probe (Applied Biosystem). To investigate the relationship between the SNP of (IL-13) (rs 20541 A/G) gene and HBV, we used real-time PCR.
resultsThe IL13 (rs20541 A/G) gene polymorphism study identified more frequent occurrences of the A/G and A/A genotypes among the patients (OR = {62.536, 21.25}, CI = {[19.276-202.889], [3.055-147.8]}, P = {0.0001, 0.002}). In the patient group, the A allele frequency was markedly different from the control group's (CI = 2.614-8.229, OR = 4.638, P < 0.0001). Nevertheless, the current investigation did not find a connection between HBV fibrosis and the gene polymorphism of IL-13(rs 20541 A/G).
conclusionThe rs20541 single nucleotide polymorphism (SNP) in IL-13 gene is linked to an increased risk of HBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.